Search Results - "Cabeza Rodriguez, María Ángeles"

High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial by Zapatero, Almudena, Guerrero, Araceli, Maldonado, Xavier, Álvarez, Ana, San-Segundo, Carmen González, Rodríguez, María Ángeles Cabeza, Solé, Josep María, Olivé, Agustí Pedro, Casas, Francesc, Boladeras, Ana, de Vidales, Carmen Martín, de la Torre, María Luisa Vázquez, Vara, Susana, Sanz, Juan Luis, Calvo, Felipe A

“…The optimal duration of androgen deprivation combined with high-dose radiotherapy in prostate cancer remains controversial. The DART 01/05 trial was designed…”
Get full text

High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial by Zapatero, Almudena, Dr, Guerrero, Araceli, MD, Maldonado, Xavier, MD, Alvarez, Ana, MD, Segundo, Carmen Gonzalez San, PhD, Rodríguez, Maria Angeles Cabeza, MD, Macias, Victor, PhD, Olive, Agustí Pedro, MD, Casas, Francesc, PhD, Boladeras, Ana, MD, de Vidales, Carmen Martín, PhD, de la Torre, Maria Luisa Vazquez, MD, Villà, Salvador, PhD, de la Haza, Aitor Perez, MSc, Calvo, Felipe A, Prof

“…Summary Background The optimum duration of androgen deprivation combined with high-dose radiotherapy in prostate cancer remains undefined. We aimed to…”
Get full text

Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study by Zapatero, Almudena, Gómez-Caamaño, Antonio, Cabeza Rodriguez, María Ángeles, Muinelo-Romay, Laura, Martin de Vidales, Carmen, Abalo, Alicia, Calvo Crespo, Patricia, Leon Mateos, Luis, Olivier, Carlos, Vega Piris, Lorena Vega

“…Circulating tumor cells (CTCs) are an established prognostic marker in castration-resistant prostate cancer but have received little attention in localized…”
Get full text

Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy by Henríquez López, Iván, González-San Segundo, Carmen, Vegas, Jesús Olivera, Gutierrez, Cristina, Hervas, Asunción, Cabeza Rodriguez, María Ángeles, Valero Albarrán, Jeannette, Rodríguez Villalba, Silvia, Álvarez Gonzalez, Ana, Sancho Pardo, Gemma, Zapatero, Almudena, Álvaro, Pedro Cuesta

“…Brachytherapy (BT) is widely used for salvage therapy in patients with biochemical failure (BF) after radiotherapy for prostate cancer (PCa). Although…”
Get full text

Late Radiation and Cardiovascular Adverse Effects After Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Results From the DART 01/05 Randomized Phase 3 Trial by Zapatero, Almudena, Guerrero, Araceli, Maldonado, Xavier, Álvarez, Ana, González-San Segundo, Carmen, Cabeza Rodriguez, Maria Angeles, Macías, Victor, Pedro Olive, Agustí, Casas, Francesc, Boladeras, Ana, Martín de Vidales, Carmen, Vázquez de la Torre, Maria Luisa, Calvo, Felipe A.

“…To present data on the late toxicity endpoints of a randomized trial (DART 01/05) conducted to determine whether long-term androgen deprivation (LTAD) was…”
Get full text

Quality of life in low-risk prostate cancer treated with surgery, external beam radiotherapy, and brachytherapy: A prospective, multicentric cohort study by Cascales, Almudena, Colmenero, Maria, Rodriguez, Alfredo, Samper, Pilar, Valero, Jeanette, Gonzalez Sansegundo, Carmen, Cabrera, Jose Andres, Gomez-Veiga, Francisco, Couselo, Maria Luz, Garcia Gomez, Borja, Hernando Arteche, Alberto, Ponce Diaz-Reixa, Jose, Rubio, Carmen, Rodriguez Cabrera, Maite, Martin-Arriscado, Cristina, Lora, David, Cabeza Rodriguez, Maria Angeles

“…Abstract only…”
Get full text

Long-term versus short-term androgen deprivation combined with high-dose radiotherapy for intermediate and high-risk prostate cancer: A randomized controlled trial (DART01/05) by Zapatero, Almudena, Guerrero, Araceli, Maldonado, Xavier, Alvarez, Ana, González San Segundo, Carmen, Cabeza Rodriguez, Maria Angeles, Macías, Victor, Casas, Francesc, Pedro-Olivé, Agustí, Boladeras, Ana Maria, Martin de Vidales, Carmen, Vazquez de La Torre, Maria Luisa, Villà, Salvador, Calvo, Felipe A.

“…Abstract only…”
Get full text

Retrospective analysis of 132 patients with stage I seminoma: Observation versus adjuvant radiation or chemotherapy in a single institution by Vega, Estela, Cascales, Almudena, De Velasco, Guillermo, Cabeza Rodriguez, Maria Angeles, Parrilla, Lucia, Colmenero, Maria, Manneh, Ray, D'Ambrosi, Rafael, Pascual, Tomas, Rodriguez Garcia, Sofia, Valdiviezo, Natalia, Gomez Ordonez, Silvia, Dorta, Miriam, Guardado, Sandra, Bartolome, Adela, Lechuga, Carmen, Perez Regadera, Jose Fermin, Lanzos Gonzalez, Eduardo, Cortes-Funes, Hernan

“…Abstract only e15033 Background: Classically, radiotherapy (RT) has been the standard adjuvant treatment for stage I seminoma patients. Improvements in early…”
Get full text